Professional role
He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative[1]
AF
whose work has been funded by the VA, NIH, and private foundation grants for more than two decades
identifying genetic variants increasing the risk of schizophrenia and bipolar disorder · This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics · understudied populations such as those of African and Latino ancestry
Reviewed sources document identifying genetic variants increasing the risk of schizophrenia and bipolar disorder, This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics, and understudied populations such as those of African and Latino ancestry. Explore attributed publications and research affiliations.
Explore researchHe is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative[1]
He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup[1]
Professor and Chair of the Department[1]
psychiatric genetics researcher[1]
identifying genetic variants increasing the risk of schizophrenia and bipolar disorder[1]
This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics[1]
understudied populations such as those of African and Latino ancestry[1]
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
11 source claims · Reviewed Sep 9, 2026
Biographical context: whose work has been funded by the VA, NIH, and private foundation grants for more than two decades
Ayman Fanous, MD, Professor and Chair of the Department, is a psychiatric genetics researcher whose work has been funded by the VA, NIH, and private foundation grants for more than two decades. His lab is interested in identifying genetic variants increasing the risk of schizophrenia and bipolar disorder in both large population and family-based samples. In particular, this work has recently focused on understudied populations such as those of African and Latino ancestry. He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup, which includes investigators from dozens of institutions in Europe, North America, and Asia. He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative, which aims to use AI to improve healthcare outcomes for veterans. This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics in VA’s landmark Million Veteran Program (MVP).
Degree: MD
Ayman Fanous, MD, Professor and Chair of the Department, is a psychiatric genetics researcher whose work has been funded by the VA, NIH, and private foundation grants for more than two decades. His lab is interested in identifying genetic variants increasing the risk of schizophrenia and bipolar disorder in both large population and family-based samples. In particular, this work has recently focused on understudied populations such as those of African and Latino ancestry. He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup, which includes investigators from dozens of institutions in Europe, North America, and Asia. He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative, which aims to use AI to improve healthcare outcomes for veterans. This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics in VA’s landmark Million Veteran Program (MVP).
Identity: Ayman Fanous, MD
Ayman Fanous, MD, Professor and Chair of the Department, is a psychiatric genetics researcher whose work has been funded by the VA, NIH, and private foundation grants for more than two decades. His lab is interested in identifying genetic variants increasing the risk of schizophrenia and bipolar disorder in both large population and family-based samples. In particular, this work has recently focused on understudied populations such as those of African and Latino ancestry. He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup, which includes investigators from dozens of institutions in Europe, North America, and Asia. He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative, which aims to use AI to improve healthcare outcomes for veterans. This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics in VA’s landmark Million Veteran Program (MVP).
Professional role: He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative
Ayman Fanous, MD, Professor and Chair of the Department, is a psychiatric genetics researcher whose work has been funded by the VA, NIH, and private foundation grants for more than two decades. His lab is interested in identifying genetic variants increasing the risk of schizophrenia and bipolar disorder in both large population and family-based samples. In particular, this work has recently focused on understudied populations such as those of African and Latino ancestry. He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup, which includes investigators from dozens of institutions in Europe, North America, and Asia. He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative, which aims to use AI to improve healthcare outcomes for veterans. This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics in VA’s landmark Million Veteran Program (MVP).
Professional role: He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup
Ayman Fanous, MD, Professor and Chair of the Department, is a psychiatric genetics researcher whose work has been funded by the VA, NIH, and private foundation grants for more than two decades. His lab is interested in identifying genetic variants increasing the risk of schizophrenia and bipolar disorder in both large population and family-based samples. In particular, this work has recently focused on understudied populations such as those of African and Latino ancestry. He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup, which includes investigators from dozens of institutions in Europe, North America, and Asia. He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative, which aims to use AI to improve healthcare outcomes for veterans. This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics in VA’s landmark Million Veteran Program (MVP).
Professional role: Professor and Chair of the Department
Ayman Fanous, MD, Professor and Chair of the Department, is a psychiatric genetics researcher whose work has been funded by the VA, NIH, and private foundation grants for more than two decades. His lab is interested in identifying genetic variants increasing the risk of schizophrenia and bipolar disorder in both large population and family-based samples. In particular, this work has recently focused on understudied populations such as those of African and Latino ancestry. He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup, which includes investigators from dozens of institutions in Europe, North America, and Asia. He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative, which aims to use AI to improve healthcare outcomes for veterans. This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics in VA’s landmark Million Veteran Program (MVP).
Professional role: psychiatric genetics researcher
Ayman Fanous, MD, Professor and Chair of the Department, is a psychiatric genetics researcher whose work has been funded by the VA, NIH, and private foundation grants for more than two decades. His lab is interested in identifying genetic variants increasing the risk of schizophrenia and bipolar disorder in both large population and family-based samples. In particular, this work has recently focused on understudied populations such as those of African and Latino ancestry. He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup, which includes investigators from dozens of institutions in Europe, North America, and Asia. He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative, which aims to use AI to improve healthcare outcomes for veterans. This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics in VA’s landmark Million Veteran Program (MVP).
Official profile: Official profile
Ayman Fanous, MD, Professor and Chair of the Department, is a psychiatric genetics researcher whose work has been funded by the VA, NIH, and private foundation grants for more than two decades. His lab is interested in identifying genetic variants increasing the risk of schizophrenia and bipolar disorder in both large population and family-based samples. In particular, this work has recently focused on understudied populations such as those of African and Latino ancestry. He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup, which includes investigators from dozens of institutions in Europe, North America, and Asia. He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative, which aims to use AI to improve healthcare outcomes for veterans. This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics in VA’s landmark Million Veteran Program (MVP).
Research interests: identifying genetic variants increasing the risk of schizophrenia and bipolar disorder
His lab is interested in identifying genetic variants increasing the risk of schizophrenia and bipolar disorder in both large population and family-based samples.
Research interests: This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics
Ayman Fanous, MD, Professor and Chair of the Department, is a psychiatric genetics researcher whose work has been funded by the VA, NIH, and private foundation grants for more than two decades. His lab is interested in identifying genetic variants increasing the risk of schizophrenia and bipolar disorder in both large population and family-based samples. In particular, this work has recently focused on understudied populations such as those of African and Latino ancestry. He plays a leading role in the Psychiatric Genomics Consortium Schizophrenia Workgroup, which includes investigators from dozens of institutions in Europe, North America, and Asia. He is also deeply involved in the VA-Department of Energy Artificial Intelligence initiative, which aims to use AI to improve healthcare outcomes for veterans. This work utilizes deep learning and genome-wide association to identify risk factors for metabolic adverse effects in patients treated with antipsychotics in VA’s landmark Million Veteran Program (MVP).
Research interests: understudied populations such as those of African and Latino ancestry
In particular, this work has recently focused on understudied populations such as those of African and Latino ancestry.